Literature DB >> 20864614

Clinically significant change in stroke volume in pulmonary hypertension.

Serge A van Wolferen1, Marielle C van de Veerdonk1, Gert-Jan Mauritz1, Wouter Jacobs1, J Tim Marcus2, Koen M J Marques3, Jean G F Bronzwaer3, Martijn W Heymans4, Anco Boonstra1, Pieter E Postmus1, Nico Westerhof1, Anton Vonk Noordegraaf5.   

Abstract

BACKGROUND: Stroke volume is probably the best hemodynamic parameter because it reflects therapeutic changes and contains prognostic information in pulmonary hypertension (PH). Stroke volume directly reflects right ventricular function in response to its load, without the correction of compensatory increased heart rate as is the case for cardiac output. For this reason, stroke volume, which can be measured noninvasively, is an important hemodynamic parameter to monitor during treatment. However, the extent of change in stroke volume that constitutes a clinically significant change is unknown. The aim of this study was to determine the minimal important difference (MID) in stroke volume in PH.
METHODS: One hundred eleven patients were evaluated at baseline and after 1 year of follow-up with a 6-min walk test (6MWT) and cardiac MRI. Using the anchor-based method with 6MWT as the anchor, and the distribution-based method, the MID of stroke volume change could be determined.
RESULTS: After 1 year of treatment, there was, on average, a significant increase in stroke volume and 6MWT. The change in stroke volume was related to the change in 6MWT. Using the anchor-based method, an MID of 10 mL in stroke volume was calculated. The distribution-based method resulted in an MID of 8 to 12 mL.
CONCLUSIONS: Both methods showed that a 10-mL change in stroke volume during follow-up should be considered as clinically relevant. This value can be used to interpret changes in stroke volume during clinical follow-up in PH.

Entities:  

Mesh:

Year:  2010        PMID: 20864614     DOI: 10.1378/chest.10-1066

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

Review 1.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

2.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

Review 3.  Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?

Authors:  Alison M MacKenzie; Andrew J Peacock
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

Review 4.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

Review 5.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

6.  Reproducibility of peak filling and peak emptying rate determined by cardiovascular magnetic resonance imaging for assessment of biventricular systolic and diastolic dysfunction in patients with pulmonary arterial hypertension.

Authors:  Christoffer Göransson; Niels Vejlstrup; Jørn Carlsen
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-22       Impact factor: 2.357

Review 7.  Use of Cardiac Imaging to Evaluate Cardiac Function and Pulmonary Hemodynamics in Patients with Heart Failure.

Authors:  Tomoko S Kato; Masao Daimon; Toru Satoh
Journal:  Curr Cardiol Rep       Date:  2019-05-10       Impact factor: 2.931

Review 8.  Pulmonary Arterial Hypertension and the Sex Hormone Paradox.

Authors:  Andrew Foderaro; Corey E Ventetuolo
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

9.  Balloon pulmonary angioplasty improves interventricular dyssynchrony in patients with inoperable chronic thromboembolic pulmonary hypertension: a cardiac MR imaging study.

Authors:  Yuzo Yamasaki; Michinobu Nagao; Kohtaro Abe; Kazuya Hosokawa; Satoshi Kawanami; Takeshi Kamitani; Torahiko Yamanouchi; Koshin Horimoto; Hidetake Yabuuchi; Hiroshi Honda
Journal:  Int J Cardiovasc Imaging       Date:  2016-09-26       Impact factor: 2.357

Review 10.  State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series).

Authors:  Mariëlle C van de Veerdonk; J Tim Marcus; Harm-Jan Bogaard; Anton Vonk Noordegraaf
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.